September 19, 2013 Press Release Mitsubishi Tanabe Pharma Corporation
Mitsubishi Tanabe Pharma to Open Singapore Office
Osaka, Japan, September 19, 2013---Mitsubishi Tanabe Pharma Corporation (President & Representative Director, CEO: Michihiro Tsuchiya,) announced today that the company will open a representative office in Singapore on October 1 this year.
Mitsubishi Tanabe Pharma Corporation has been operating its Southeast Asian business through P.T. Tanabe Indonesia, a sales and manufacturing subsidiary of the Company. Aiming further contribution to medical care in Southeast Asian counties, the Company will supply pharmaceuticals that meet the regional market needs determined by the newly opened office in Singapore, a center of the ASEAN economy, high level medical technology, and medical information. The planned Singapore office will serve as a base to manage the operation of Mitsubishi Tanabe Pharma's pharmaceutical business in Southeast Asia, while P.T. Tanabe Indonesia will be positioned as a manufacturing base of Southeast Asian countries. The Company will endeavor to build a business structure for effective and efficient operations in the Southeast Asian region.
Establishing the foundation for expanded overseas operations has been set as a major business strategy under our Medium-Term Management Plan 11-15, New Value Creation. Mitsubishi Tanabe Pharma Corporation will expand its pharmaceutical business in the Southeast Asian market, which is expected to grow even further in the future.